Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -64.3% | +69.7% | 2 / 3 | +13.4% | +0.44 pp | -1.09 pp | +4.5% | 0.00 | 14.48 | 525 | +13,4% | 2,6 | −64,3% | 14.48 | 24.54 | −41,0% |
| Pts | 0 | 12 | 8 | 4 | 8 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 8.700 (close price on 2026-10-19)EPS (TTM): 600,7
Financial charts
1.Revenue & growth
VND bn525Q3/26
1.Revenue & growth
VND bn525Q3/26
2.Profit & growth
VND bn2,63Q3/26
3.Profit mix (Penman)
VND bn8,92Q3/26
4.Margins & cost structure
%8.0%Q3/26
5.Returns & cash cycle
% · days-78.7%Q3/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn372Q3/26
8.Funding & debt health
VND bn · times372Q3/26
9.Revenue backlog
VND bn6,17Q3/26
10.Valuation
times · %14,5×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %230Q3/26
Adjusted EPS growth, latest quarter
-64.3%
Average adjusted EPS growth, 3 quarters
102%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26